"A ship is safe in harbor, but that's not what ships are for." –William G.T. Shedd Source: IMPhoto1/Shutterstock Life presents us with defining moments—opportunities to step forward into the unknown ...

Markets are doubting U.S. growth and equity strength. Yet economic conditions don’t signal a downturn. Resilient earnings keep us overweight U.S. stocks. Global stocks trimmed their losses last week.

Risk rarely fails because we couldn’t detect it. Risk fails because we couldn’t converge. We couldn’t bring an uncertain situation to a clean, governable end without turning the whole product into a ...

Decision making under risk and uncertainty encompasses a broad spectrum of theoretical and empirical approaches aimed at understanding how individuals evaluate probabilistic outcomes under various ...

WASHINGTON (AP) — Federal Reserve officials agreed earlier this month to hold off on any interest-rate moves while they evaluated the impact of President Donald Trump's tariffs on inflation, ...

Discover how the risk-adjusted discount rate reflects investment risk and return, helping you to evaluate the valuation of projects with potential risk.

Arch Resources, Inc. (ARCH) has disclosed a new risk, in the Corporate Activity and Growth category. The merger between Arch Resources, Inc. and CONSOL poses significant risks, as uncertainty ...

This workshop series provided a venue for stakeholders to discuss structured approaches to characterize and communicate the sources of uncertainty in benefit-risk assessment in drug development and ...

Fed leaves interest rates unchanged at May 6-7 meeting. Officials more concerned about inflation than unemployment. Cited Trump tariffs as a factor influencing inflation risk. Fed minutes show ...

Risk aversion is a fundamental trait shaping how individuals, firms and policymakers respond to uncertain outcomes. It encapsulates the preference for certain outcomes over gambles with equivalent ...

This workshop series provided a venue for stakeholders to discuss structured approaches to characterize and communicate the sources of uncertainty in benefit-risk assessment in drug development and ...